Redhill Biopharma
RDHL
#10900
Rank
โ‚น0.39 B
Marketcap
โ‚น64.21
Share price
-4.29%
Change (1 day)
-54.60%
Change (1 year)

EPS for Redhill Biopharma (RDHL)

EPS in 2023 (TTM): -โ‚น53,915

According to Redhill Biopharma's latest financial reports the company's current EPS (TTM) is -โ‚น67,089. In 2017 the company made an earnings per share (EPS) of -โ‚น2,39,605 a decrease over its 2016 EPS that were of -โ‚น2,10,852.

EPS history for Redhill Biopharma from 2013 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-โ‚น53,915
2017-โ‚น2,39,60513.64%
2016-โ‚น2,10,8529.12%
2015-โ‚น1,93,22668.01%
2014-โ‚น1,15,010-25.93%
2013-โ‚น1,55,264

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Sanofi
SNY
โ‚น245.32-100.37%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
โ‚น342.62-100.51%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚น372.47-100.56%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
โ‚น131.30-100.20%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Taro Pharmaceutical
TARO
โ‚น116.93-100.17%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel